Reach Us +44-1904-929220
Biopolymer Nanotherapeutics: Enabling Oncology Drug Development By Nanoconjugates & Nanoparticles | 3688

Journal of Molecular Biomarkers & Diagnosis
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences

15th Global Biomarkers and Clinical Research Summit

Vienna, Austria

2nd International Conference on Biomarkers and Cancer Targets

Capetown, South Africa
Share This Page

Biopolymer Nanotherapeutics: Enabling oncology drug development by Nanoconjugates & nanoparticles

2nd World Congress on Biomarkers & Clinical Research

Anita Kamra Verma

ScientificTracks Abstracts: J Mol Biomark Diagn

DOI: 10.4172/2155-9929.S1.2

Fluorescence resonance energy transfer (FRET) is a distance-dependent interaction between two chromophores in which excitation is transferred from a donor molecule (fl uorophore) to an acceptor molecule (quencher) without photon emission. Removal of the acceptor molecule from donor?s proximity results in quantifi able fl uorescence (Figure 1). FRET is an important technique and can be utilized in monitoring peptide substrate cleavage by proteases in diff erent biological samples. We report a simple, sensitive, specifi c FRET based platform for detection of proteases profi les in diff erent biological samples by screening against a combinatorial library of internally quenched peptide probes (IQFP?s). Th e library was utilized to determine the proteolytic profi le of two clinically relevant biological fl uids, serum and bronchoalveolar lavage fl uid. Both fl uids displayed a distinct and quantifi able proteolytic signature. Th e library was further utilized to distinguish between the protease profi les of diff erent Aspergillus species and also to identify peptide probes that are indicative of invasive aspergillosis (IA) in a guinea pig model. Substrate specifi city of biologically relevant recombinant enzymes such as prolyl oligopeptidase (POP) and fi broblast activation protein (FAP) both of which are implicated in number of human diseases was also determined using the IQFP library screen. Th e approach provides a comprehensive fi nger print of the proteolytic activity of complex biological fl uids as well as individual proteases. Th e technology is currently being applied to identify proteases as biomarkers in a variety of disease states for subsequent development of in vitro diagnostics.
Kalyani Jambunathan is a researcher at SRI International?s Center for Advanced Drug Research (CADRE), at present working on NIAID funded project to develop FRET based assay to detect fungal derived proteolytic activity during invasive Aspergillosis. She graduated with a BSc in chemistry from Madras Christian College (MCC, India), MSc in chemistry from Indian Institute of Technology-Madras (IIT-M) and PhD in chemistry under the guidance of Dr. H. Mario Geysen in Department of Chemistry at University of Virginia. Her areas of specialization include but not limited to peptide science, molecular biology, assay design and development.
Relevant Topics